Expand FDA approval of LDN for Cancer/ Autoimmune Dz

[Anavic_Pascarella]

Achieve FDA approval of Low Dose Naltrexone in the use of autoimmune conditions/ cancers so patients can get these treatment options more routine offered, prescribed and covered by insurance at their local pharmacy.; easier accessibility and more affordable.

LDN Research Trust